• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Large Study Finds Antipsychotic Use During First Trimester Does Not Increase Risk of Malformations

Large Study Finds Antipsychotic Use During First Trimester Does Not Increase Risk of Malformations

December 5, 2016
Bret A. Moore, PsyD, ABPP
bret-a-moore-psyd-abppBret A. Moore, PsyD, ABPP Board-Certified Clinical Psychologist, San Antonio, TX Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Review of: Huybrechts KF, Hernández-Díaz S, Patorno E, et al. Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiatry 2016;73(9):938–946.

Study Type: Retrospective cohort study

The use of antipsychotics during pregnancy has doubled over the past decade, and there have been ongoing concerns about the risk of congenital malformations. In the May issue of TCPR, we reviewed a pregnancy registry study showing no significant association between atypical antipsychotic use and major malformation (Cohen L et al, JAMA Psychiatry 2016;173:263–270). Another study was just published reinforcing those results by looking at a larger population.

Using national Medicaid data, researchers identified pregnant women who filled at least one antipsychotic prescription during their first trimester, the most critical time for fetal development. Out of over 1.3 million women between 12 and 55 years of age, 9,258 (0.69%) filled an atypical antipsychotic (eg, ­olanzapine) and 733 (0.05%) filled a typical antipsychotic (eg, haloperidol). The study outcomes were straightforward: risk of overall congenital and cardiac malformations identified within 90 days after delivery.

Prior to adjusting for potential study confounders (eg, psychiatric and physical comorbidities), the risk of congenital malformations was higher in women treated with atypicals (44.5 per 1,000 births) and typicals (38.2 per 1,000 live births) compared to those not treated (32.7 per 1,000 live births). However, the women prescribed antipsychotics were older, had higher rates of psychiatric and medical comorbidities, and took more psychiatric and teratogenic medications. Once the researchers controlled for these factors, there were no significant differences between the groups in the rates of overall congenital nor cardiac ­malformations.

One outlier, however, was risperidone. Risperidone had a 26% increased risk for causing both overall or cardiac malformations than no antipsychotic, but this increased risk was only statistically significant for overall malformations, not cardiac malformations.

TCPR’s Take

A major strength of the article is the sample size, which is about 17 times the size of any previous study on the topic. It’s not clear what to make of the finding that risperidone may be the only teratogenic antipsychotic. More data should help clarify this issue.

Practice Implications

Explain to patients that the baseline rate of malformations in all women (even those who are not taking any medication) is around 2%–4%, and that large studies have shown that antipsychotics are unlikely to increase the risk. For the time being, risperidone should be at the bottom of your list if an antipsychotic must be prescribed during pregnancy.
    Bret a moore psyd abpp
    Bret A. Moore, PsyD, ABPP

    Good News for Smoking Cessation Drugs: Not as Scary as Once Thought

    More from this author
    Carlat Total Access Subscriptions: Get access to every article on the website.

    Complete access to every article you search on the website.

    Shop for Total Access
    Free Psychiatry Updates
    The latest unbiased psychiatric information sent to your inbox.
    Specify Your Interests
    Featured Book
    • HospPsychiatry_Spiral_Binding_Sm.png

      Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

      This comprehensive guide is designed to be a valuable resource for professionals working in...
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2603816031.jpg
      General Psychiatry

      A Scam for Every Woman, Child, and Man: Part 2

      1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.